Public Policy and Advocacy Committee

 View Only
last person joined: 2 years ago 

The Policy and Advocacy Committee reviews and analyzes immunotherapy and oncology related policy issues to advise the Board of Directors on the broad policy, advocacy, regulatory and value priorities of the society. The committee serves at the pleasure of the Board of Directors, representing the society when requested and supporting the development of talking points for the board when asked. The committee works with relevant subcommittees to achieve its purpose.

SITC Responds to NCI Request for Information

By Christian Miller posted 06-03-2020 08:51

  
Recently the National Cancer Institute had issued a Request for Information (RFI) asking the field for ways in which current cancer research could be of possible use against COVID19. The SITC Science and Research Subcommittee led a response letter describing a few ways in which research being done by SITC members could possibly assist. The full text for this letter can be found here and the RFI can be found here. 

Permalink